Thailand Bans Recreational Cannabis, Permits Medical Use in 2026

Medical-Only Framework Replaces Open Market

Thailand's 2026 cannabis law restricts legal sales to medical dispensaries operating under prescription requirements, ending the unregulated retail market that emerged after 2022 decriminalization. The Ministry of Public Health published final regulations in September 2026 that require patients to obtain prescriptions from licensed physicians before purchasing cannabis products. Recreational sales, public consumption, and non-medical marketing are now prohibited under penalties that include fines up to 60,000 baht and potential jail time.

The shift hits hard. An estimated 6,000 cannabis shops opened between 2022 and 2025 under the assumption that recreational sales would stay legal. Many operators now face a choice: convert to medical-only models with stricter licensing, or close.

Prescription and Licensing Requirements

Legal cannabis purchases require a doctor's prescription specifying dosage and treatment duration, with dispensaries needing Ministry of Public Health licenses to operate. Patients must register with Thailand's medical cannabis program and receive evaluations for qualifying conditions including chronic pain, epilepsy, and nausea related to chemotherapy. The prescription model mirrors frameworks in Germany and Australia rather than the adult-use systems in Canada or parts of the United States.

Dispensary licenses cost 10,000 baht annually. They require pharmacist oversight during operating hours, and products must display THC content, dosage instructions, and health warnings in Thai language.

THC Limits and Product Standards

Edible products are capped at 5 mg THC per serving, while flower sales require tamper-evident packaging and lab testing for potency and contaminants. The 5 mg limit aligns with cautious dosing standards seen in early-stage medical programs but falls below the 10 mg standard common in U.S. medical markets. Flower products can contain higher THC percentages but must be sold in child-resistant containers with batch-specific lab certificates.

Extracts and concentrates face tighter rules. High-potency products above 20% THC require enhanced labeling and can only be dispensed to patients with documented tolerance or specific medical needs.

Tourism and Enforcement Variables

The law creates uncertainty for Thailand's cannabis tourism sector, which had drawn visitors to Bangkok and Phuket dispensaries since 2022. Tourists can't legally purchase cannabis without Thai medical documentation, effectively closing the recreational market that had become a draw for international travelers. Enforcement priorities aren't settled yet—some provinces may tolerate existing shops during a transition period, while others have already begun closure orders.

For context on how other Southeast Asian countries are handling cannabis policy, see the CannIntel topic hub on Thailand Cannabis Legalization.

What Happens Next

Dispensaries have until December 2026 to comply with the new medical framework or cease operations. The Thai Cannabis Corporation, a state enterprise, will control cultivation licensing and may become the primary wholesale supplier to licensed dispensaries. Enforcement will vary by region—Bangkok's regulatory agencies have signaled stricter oversight than rural provinces, where local officials may adopt wait-and-see approaches.

The political variable matters. Opposition parties are already calling the restrictions too harsh and may push for amendments if they gain legislative influence in 2027. This is unsettled.